Literature DB >> 12438605

Upregulation of CD40 expression on endothelial cells infected with human cytomegalovirus.

Tim Maisch1, Barbara Kropff, Christian Sinzger, Michael Mach.   

Abstract

CD40 has been identified as an important molecule for a number of processes, such as immune responses, inflammation, and the activation of endothelia. We investigated CD40 in endothelial cells (EC) following infection with an endotheliotropic strain of human cytomegalovirus (HCMV). Between 8 and 72 h postinfection, we observed a significant increase in CD40 levels on the surface of infected EC, as measured by fluorescence-activated cell sorting analysis. As a consequence of CD40 upregulation, increased levels of E-selectin were found on infected EC after stimulation with CD154-expressing T cells. Enhanced expression of CD40 was specific for EC, since infection of fibroblasts did not result in the upregulation of CD40. The addition of neutralizing antibodies as well as UV inactivation of virus completely prevented the upregulation of CD40 on EC. Also, laboratory-adapted HCMV strain AD169 was not able to induce CD40 on EC. De novo protein synthesis was necessary for the increased surface expression. At early times (4 to 24 h) postinfection, this change was not accompanied by increased levels of CD40 protein or mRNA. At late times (48 to 96 h) postinfection, increased amounts of CD40 protein and mRNA were detected. Immunohistochemical analysis of infected tissues demonstrated elevated levels of CD40 on HCMV-infected EC in vivo. Thus, infection of EC by HCMV may result in the activation of endothelia and in the augmentation of inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438605      PMCID: PMC136694          DOI: 10.1128/jvi.76.24.12803-12812.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus.

Authors:  J E Grundy; K L Downes
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

2.  Identification of multiple strains of cytomegalovirus in homosexual men.

Authors:  A C Collier; S H Chandler; H H Handsfield; L Corey; J K McDougall
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Herpesvirus morphology: visualization of a structural subunit.

Authors:  J Almeida; D Lang; P Talbot
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

4.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

Authors:  M T Grattan; C E Moreno-Cabral; V A Starnes; P E Oyer; E B Stinson; N E Shumway
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

5.  T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells.

Authors:  W J Waldman; P W Adams; C G Orosz; D D Sedmak
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

6.  Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55.

Authors:  Y Ohizumi; H Suzuki; Y Matsumoto; Y Masuho; Y Numazaki
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

7.  Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.

Authors:  K Tokunaga; Y Nakamura; K Sakata; K Fujimori; M Ohkubo; K Sawada; S Sakiyama
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

8.  Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.

Authors:  Y Yamashita; K Shimokata; S Mizuno; H Yamaguchi; Y Nishiyama
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements.

Authors:  B Liu; M F Stinski
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).

Authors:  S Lederman; M J Yellin; A Krichevsky; J Belko; J J Lee; L Chess
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV.

Authors:  Gretchen L Bentz; Marta Jarquin-Pardo; Gary Chan; M Shane Smith; Christian Sinzger; Andrew D Yurochko
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

3.  Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells.

Authors:  Winnie W Henderson; Rebecca Ruhl; Paul Lewis; Matthew Bentley; Jay A Nelson; Ashlee V Moses
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 4.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

5.  Acute cytomegalovirus infection and transient carotid intimal-medial thickening in a young, otherwise healthy woman.

Authors:  Yasuhiko Hirabayashi; Tomonori Ishii; Takao Kodera; Hiroshi Fujii; Yasuhiko Munakata; Takeshi Sasaki
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza.

Authors:  André Ballesteros-Tato; Beatriz León; Frances E Lund; Troy D Randall
Journal:  J Exp Med       Date:  2013-07-08       Impact factor: 14.307

7.  miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1).

Authors:  Hosni A M Hussein; Shaw M Akula
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.